Marked differences in practice exist between cancer registries, for example, with respect to data sources, definitions and processing methods.
To make cancer registry data comparable, which is one of the main aims of the Network, it is important that common rules and definitions are used.
| Title | Year of Publication | Link |
|---|---|---|
| Treatment Data Recording | 2025 | EN |
| Recording Recurrence, Progression and Transformation Episodes | 2025 | EN |
| Central Nervous System Tumours | 2024 | EN |
| Standard dataset | 2023 | EN ES FR |
| Basis of Diagnosis | 2022 | EN ES FR RO DE |
| Cancer cases in migrant population | 2022 | EN FR ES |
| Recording and Reporting of Urothelial Tumours | 2022 | EN ES FR RO |
| Incidence Date | 2022 | EN ES FR DE RO |
| The Toronto Childhood Cancer Stage Guidelines | 2016 | Read more |
| Common data quality checks for European cancer registries | 2023, updated 2024 | EN |
| Haematological cancers | 2014 | EN Position paper |
| Data protection | 2012 | EN Position paper |
| Multiple Primaries | 2004 | EN |
| Bladder Tumours | 1995 | EN FR DE ES |
| Tumours of the Brain and Central Nervous System | 1998 | EN |
| Non-Melanoma Skin Cancers | 2000 | EN |
| Method of Detection in Relation to Screening | 2001 | EN |
| Confidentiality in Cancer registration | 2002 | EN FR |
| Condensed TNM for Coding the Extent of Disease | 2002 | EN FR |
| Structured Registry Review | EN |